MRVL Form 144: Notice for 10,000 Common Shares

MRVL submitted a Form 144 notice for proposed sales of common stock, listing 10,000 shares and an aggregate value of $1,355,000.00 with a filing date of 04/17/2026.

Rhea-AI Filing Summary

MRVL submitted a Form 144 notice for proposed sales of common stock, listing 10,000 shares and an aggregate value of $1,355,000.00 with a filing date of 04/17/2026. The notice itemizes 2,585 restricted shares and 7,415 performance shares dated 04/15/2026, and reports recent completed sales of 6,900, 10,854, and 7,000 common shares on 04/06/2026, 04/02/2026 and 04/01/2026 respectively with the reported proceeds.

Insights

Securities Compliance Analyst

Routine Form 144 sale notice showing scheduled and recent affiliate sales.

The filing lists proposed resale of common stock and specifies the security types as restricted stock and performance shares, with exact share counts and dates. The document also records multiple sales executed in early April with explicit share counts and proceeds.

There is no indication in the excerpt of regulatory qualifiers beyond standard Form 144 reporting; timing and cash‑flow treatment follow usual resale disclosure practice and are reflected by the reported sale dates and proceeds in the table.

Key Figures

Proposed shares listed: 10,000 shares Aggregate reported value: $1,355,000.00 Restricted Stock: 2,585 shares +4 more

7 metrics

Proposed shares listed 10,000 shares listed in filing header dated 04/17/2026

Aggregate reported value $1,355,000.00 appears beside the 10,000‑share line dated 04/17/2026

Restricted Stock 2,585 shares listed as securities to be sold, dated 04/15/2026

Performance Shares 7,415 shares listed as securities to be sold, dated 04/15/2026

Sale on 04/06/2026 6,900 shares sold by Mark J. & Stephanie Casper Trust for $755,205.00

Sale on 04/02/2026 10,854 shares sold by Mark Casper for $1,161,453.98

Sale on 04/01/2026 7,000 shares sold by Mark Casper for $735,735.00

Key Terms

Restricted Stock, Performance Shares, Form 144, Issuer

4 terms

Restricted Stock financial

"Common | 04/15/2026 | Restricted Stock | Issuer | | | 2585"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Performance Shares financial

"Common | 04/15/2026 | Performance Shares | Issuer | | | 7415"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Issuer regulatory

"Restricted Stock | Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does MRVL's Form 144 disclose about shares being offered?

The Form 144 discloses a proposed sale of 10,000 common shares with an aggregate value of $1,355,000.00 as of 04/17/2026. It also lists 2,585 restricted shares and 7,415 performance shares dated 04/15/2026.

Which insider or entity reported recent sales in the MRVL filing?

The filing shows sales by the Mark J. & Stephanie Casper Trust and Mark Casper on early April dates. Reported sales include 6,900, 10,854, and 7,000 shares with stated proceeds.

What proceeds were reported for recent MRVL insider sales?

Reported proceeds include $755,205.00 for 6,900 shares, $1,161,453.98 for 10,854 shares, and $735,735.00 for 7,000 shares, with sale dates in April 2026.

Are the securities to be sold identified by type in the MRVL Form 144?

Yes; the filing specifies the securities as Restricted Stock (2,585 shares) and Performance Shares (7,415 shares), each dated 04/15/2026 in the excerpt.

On which exchange is the MRVL security listed according to the excerpt?

The excerpt lists NASDAQ as the exchange associated with the common securities in the filing meta‑line dated 04/17/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/17/2026 - 04:06 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002007961
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MARVELL TECHNOLOGY, INC.
SEC File Number	001-40357
Address of Issuer	1000 N. West Street, Suite 1200 Wilmington DELAWARE 19801
Phone	(302) 295 - 4840
Name of Person for Whose Account the Securities are To Be Sold	MARK CASPER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	1355000.00	874300000	04/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/15/2026	Restricted Stock	Issuer			2585	04/15/2026	Not Applicable
Common	04/15/2026	Performance Shares	Issuer			7415	04/15/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MARK J.& STEPHANIE CASPER TRUST 1000 N. West Street, Suite 1200 Wilmington DE 19801	Common	04/06/2026	6900	755205.00
MARK CASPER 1000 N. West Street, Suite 1200 Wilmington DE 19801	Common	04/02/2026	10854	1161453.98
MARK CASPER 1000 N. West Street, Suite 1200 Wilmington DE 19801	Common	04/01/2026	7000	735735.00

144: Remarks and Signature

Remarks
Date of Notice	04/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mark Casper
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)